Literature DB >> 31499147

Racial differences in dermatologic conditions associated with HIV: A cross-sectional study of 4679 patients in an urban tertiary care center.

Alexandra M Bender1, Olive Tang1, Raveena Khanna1, Sonja Ständer2, Sewon Kang1, Shawn G Kwatra3.   

Abstract

BACKGROUND: Because of reduced mortality, patients with HIV are living longer and presenting with chronic diseases. Little is known about racial differences in dermatologic conditions associated with HIV infection.
OBJECTIVE: This study examines associated dermatologic conditions in a large population of patients with HIV at a tertiary care center with a diverse patient population.
METHODS: Cross-sectional study of patients with HIV seen between July 14, 2013, and July 14, 2018, in a tertiary health care system. The burden of HIV-related dermatologic conditions was collected by using medical records. Patients with HIV were compared with control individuals of the same race, and significance was assessed using the chi-square test. A Bonferroni correction was performed to control for multiple hypothesis testing.
RESULTS: The study population (N = 4679) was 64.7% male and 69% African American, with 88.7% of patients receiving antiretroviral therapy. African American patients with HIV had a greater risk of oral hairy leukoplakia (odds ratio [OR], 64.49), herpes zoster (OR, 9.27), prurigo nodularis (OR, 8.80), and squamous cell carcinoma (OR, 5.72). LIMITATIONS: Our data describe patients seen by 1 health care system.
CONCLUSIONS: African American patients with HIV may be at increased risk for pruritic disorders compared with race-matched control individuals and white patients with HIV.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Kaposi sarcoma; antiretroviral therapy; human immunodeficiency virus; oral hairy leukoplakia; prurigo nodularis; pruritus

Mesh:

Substances:

Year:  2019        PMID: 31499147      PMCID: PMC7374638          DOI: 10.1016/j.jaad.2019.08.072

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  16 in total

Review 1.  Dermatologic manifestations of HIV infection.

Authors:  Toby A Maurer
Journal:  Top HIV Med       Date:  2005 Dec-2006 Jan

2.  Real-World Prevalence of Prurigo Nodularis and Burden of Associated Diseases.

Authors:  Amy H Huang; Joseph K Canner; Raveena Khanna; Sewon Kang; Shawn G Kwatra
Journal:  J Invest Dermatol       Date:  2019-08-15       Impact factor: 8.551

3.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Huldrych F Günthard; Michael S Saag; Constance A Benson; Carlos del Rio; Joseph J Eron; Joel E Gallant; Jennifer F Hoy; Michael J Mugavero; Paul E Sax; Melanie A Thompson; Rajesh T Gandhi; Raphael J Landovitz; Davey M Smith; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

Review 4.  Inflammatory noninfectious dermatoses of HIV.

Authors:  Ncoza C Dlova; Anisa Mosam
Journal:  Dermatol Clin       Date:  2006-10       Impact factor: 3.478

5.  Increased levels of circulating cytokines with HIV-related immunosuppression.

Authors:  Fatma M Shebl; Kai Yu; Ola Landgren; James J Goedert; Charles S Rabkin
Journal:  AIDS Res Hum Retroviruses       Date:  2011-12-02       Impact factor: 2.205

Review 6.  Emerging drugs for the treatment of pruritus.

Authors:  Sonja Ständer; Elke Weisshaar; Ulrike Raap
Journal:  Expert Opin Emerg Drugs       Date:  2015-06-02       Impact factor: 4.191

Review 7.  Dermatology of the patient with HIV.

Authors:  Mariam M Khambaty; Sam S Hsu
Journal:  Emerg Med Clin North Am       Date:  2010-05       Impact factor: 2.264

8.  A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team.

Authors:  S M Hammer; D A Katzenstein; M D Hughes; H Gundacker; R T Schooley; R H Haubrich; W K Henry; M M Lederman; J P Phair; M Niu; M S Hirsch; T C Merigan
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

9.  Inpatient Burden of Prurigo Nodularis in the United States.

Authors:  Katherine A Whang; Sewon Kang; Shawn G Kwatra
Journal:  Medicines (Basel)       Date:  2019-08-11

Review 10.  Treatment of Dermatological Conditions Associated with HIV/AIDS: The Scarcity of Guidance on a Global Scale.

Authors:  Suchismita Paul; Rachel Evans; Toby Maurer; Lulu M Muhe; Esther E Freeman
Journal:  AIDS Res Treat       Date:  2016-05-03
View more
  4 in total

1.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

Review 2.  Itch: Epidemiology, clinical presentation, and diagnostic workup.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Shawn G Kwatra
Journal:  J Am Acad Dermatol       Date:  2021-08-21       Impact factor: 11.527

3.  Racial and Gender Differences in the Presentation of Pruritus.

Authors:  Katherine A Whang; Raveena Khanna; Jamael Thomas; Crystal Aguh; Shawn G Kwatra
Journal:  Medicines (Basel)       Date:  2019-09-27

4.  Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.

Authors:  Saadet Inan; Nae J Dun; Alan Cowan
Journal:  Molecules       Date:  2021-09-11       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.